Combating resistance: application of the emerging science of pharmacokinetics and pharmacodynamics

International Journal of Antimicrobial Agents

Volumn 30, Issue SUPPL. 2, 2007, Pages 122-126

  Jacobs, Michael R ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Alexander Project; Amoxicillin clavulanate; Pharmacodynamics; Pharmacokinetics; Respiratory tract infection; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFDINIR; CEFIXIME; CEFPROZIL; CEFTRIAXONE; CEFUROXIME AXETIL; CEFUZONAM; PENICILLIN G;

ARTICLE; IN VITRO STUDY; IN VIVO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; HUMANS;

EID: 36048966401     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.07.036     Document Type: Article

References (10)

1. Dagan R., Johnson C.E., McLinn S., et al. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs azithromycin in acute otitis media. Pediatr Infect Dis J 19 (2000) 95-104
2. Craig W.A. Basic pharmacodynamics of antibacterials with clinical applications to the use of β-lactams, glycopeptides, and linezolid. Infect Dis Clin North Am 17 (2003) 479-501
3. Jacobs M.R. Anti-infective pharmacodynamics - maximizing efficacy, minimizing toxicity. Drug Discov Today 1 (2004) 505-512
4. Anon, Jacobs M.R., Poole M.D., et al. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 130 (2004) 1-45
5. Grüneberg R.N., and Felmingham D. The Alexander Project Group. Results of the Alexander Project: a continuing multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens. Diagn Microbiol Infect Dis 25 (1996) 169-181
6. Jacobs M.R., Felmingham D., Appelbaum P.C., and Grüneberg R.N. The Alexander Project Group. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 52 (2003) 229-246
7. Felmingham D., White A.R., Jacobs M.R., et al. The Alexander Project: the benefits from a decade of surveillance. J Antimicrob Chemother 56 (2005) 3-21
8. Kaye C.M., Allen A., Perry S., et al. The clinical pharmacokinetics of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate. Clin Ther 23 (2001) 578-584
9. Hoberman A., Dagan R., Leibovitz E., et al. Large dosage amoxicillin/clavulanate, compared with azithromycin, for the treatment of bacterial acute otitis media in children. Pediatr Infect Dis J 24 (2005) 525-532
10. Dagan R., Hoberman A., Johnson C., et al. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J 20 (2001) 829-837